Author/Authors :
Habibian, Samira Department of Medical Microbiology - Faculty of Medicine - Baqiyatallah University of Medical Sciences, Tehran , Mehrabi-Tavana, Ali Department of Medical Microbiology - Faculty of Medicine - Baqiyatallah University of Medical Sciences, Tehran , Ahmadi, Zyanab Baqiyatallah University of Medical Sciences, Tehran , Izadi, Morteza Baqiyatallah University of Medical Sciences, Tehran , Jonaidi, Nematolah Baqiyatallah University of Medical Sciences, Tehran , Darakhshanpoure, Jalalodin Department of Medical Microbiology - Tonokabon Azad University of Medical Sciences, Tonokabon , Salesi, Mahmode Baqiyatallah University of Medical Sciences, Tehran , Zahraei, Mohsen , Ataee, Ramezan Ali Department of Medical Microbiology - Faculty of Medicine - Baqiyatallah University of Medical Sciences, Tehran
Abstract :
Background: The development of antibiotic resistance among Streptococcus pneumoniae strains has caused significant health problems
worldwide. Objectives: The aim of this study was to determine antibiotic resistance pattern and serotypes distribution of Streptococcus pneumoniae
strains isolated from clinical specimens. Material and Methods: A total of fifty Streptococcus pneumoniae strains were isolated from Tehran Hospital’s laboratory from 2008 to 2012.
Antimicrobial susceptibility testing was performed using broth microdilution method and minimum inhibitory concentration (MIC)
of each strain was determined. to verify the resistant strains and demonstrate the presence of antibiotic resistant genes, the PCR was
performed. Results: The study showed that three strains (6%) and six strains (12%) indicated intermediate resistance and complete resistance to
penicillin, respectively, 58% strains were susceptible to ceftazidime, two ones (4%) indicated resistance to ciprofloxacin, one (2%) indicated
intermediate resistance to ceftriaxone , two strains (4%) indicated complete resistance and four (8%) strains indicated resistance to
vancomycin. Conclusions: The emergence of Streptococcus pneumoniae strains with multiple resistance needs permanent monitoring of antibiotic
susceptibility patterns of clinical isolates. We have found that ceftazidime is not a suitable drug for choosing the treatment of pneumococcal
infections.